http://www.prnewswire.com/news-releases/glaxosmithkline-to-acquire-cns-inc-56096302.htmlthe band aid for your your nose still does 150m revenue per year for gsk without being proven and without the drug delivery applications like consegna...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come